Skip to contentBRANDT ERIC — DENTSPLY INTERNATIONAL INC /DE/ insider: 471 transactions · InsiderLensBRANDT ERIC
- Director at DENTSPLY INTERNATIONAL INC /DE/ · on record since Mar 28, 2006
- Director at AVANIR PHARMACEUTICALS · on record since Feb 15, 2006
- Director at General Finance CORP · on record since Sep 14, 2023
- Director at VERTEX PHARMACEUTICALS INC / MA · on record since Jun 5, 2006
- Director at Nutanix, Inc. · on record since May 16, 2025
- Director at BioScrip, Inc. · on record since May 22, 2026
- 10% owner at DENTSPLY INTERNATIONAL INC /DE/ · on record since Jun 23, 2009
- Director at LAM RESEARCH CORP · on record since Sep 17, 2010
- EVP, CFO, CD, (PFO) at ALLERGAN INC · on record since Feb 3, 2004
- Director at YAHOO INC · on record since Mar 10, 2016
- Former EVP & CFO at BROADCOM CORP · on record since Feb 3, 2016
- Director at MACERICH CO · on record since Jun 25, 2018
- Director at SYMANTEC CORP · on record since Mar 5, 2020
- President, Chief Executive at AVANIR PHARMACEUTICALS · on record since Sep 15, 2005
Insider trading activity of BRANDT ERIC
- Transactions on record
- 471
- since Feb 3, 2004
- Open-market buys
- 5
- $238.5K
- Open-market sells
- 97
- $83.4M
- Companies traded
- 12
- last filing Jun 15, 2026
Figures computed from official regulatory filings — methodology.
Companies where BRANDT ERIC has traded
- LAM RESEARCH CORP65 tx · $47M · Jun 15, 2026
- BioScrip, Inc.4 tx · $58.8K · May 22, 2026
- Nutanix, Inc.2 tx · Dec 16, 2025
- General Finance CORP9 tx · Sep 11, 2025
- MACERICH CO7 tx · Jun 3, 2024
- DENTSPLY INTERNATIONAL INC /DE/232 tx · $6.6M · Apr 15, 2024
- SYMANTEC CORP10 tx · $105.2K · Sep 23, 2022
- YAHOO INC2 tx · Jul 5, 2016
- BROADCOM CORP118 tx · $58.1M · Feb 3, 2016
- VERTEX PHARMACEUTICALS INC / MA
Track record of BRANDT ERIC
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Feb 11, 2009
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BRANDT ERIC
Co-insiders of BRANDT ERIC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
10 tx · $1.2M · Jan 30, 2009
DERSE NATALIE MARIEGeneral Finance CORP +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 15, 2026 | Sell | -1,481 | 343.96 USD | $509.4K | SEC |
| Jun 15, 2026 | Sell | -1,653 | 356.27 USD | $588.9K | SEC |
| Jun 15, 2026 | Sell | -8,233 | 371.17 USD | $3.1M | SEC |
| Jun 15, 2026 | Sell | -1,172 | 353.52 USD | $414.3K | SEC |
| Jun 15, 2026 | Sell | -5,803 | 367.01 USD | $2.1M | SEC |
| Jun 15, 2026 | Sell | -4,030 | 368.03 USD | $1.5M | SEC |
| Jun 15, 2026 | Sell | -2,345 | 363.33 USD | $852K | SEC |
| Jun 15, 2026 | Sell | -1,756 | 361.05 USD | $634K | SEC |
| Jun 15, 2026 | Sell | -1,100 | 357.98 USD | $393.8K | SEC |
| Jun 15, 2026 | Sell | -1,455 | 357.06 USD | $519.5K | SEC |
| Jun 15, 2026 | Sell | -3,828 | 359.08 USD | $1.4M | SEC |
| Jun 15, 2026 | Sell | -780 | 359.24 USD | $280.2K | SEC |
| Jun 15, 2026 | Sell | -1,461 | 354.08 USD | $517.3K | SEC |
| Jun 15, 2026 | Sell | -3,442 | 346.79 USD | $1.2M | SEC |
| Jun 15, 2026 | Sell | -1,880 | 358.22 USD | $673.5K | SEC |
| Jun 15, 2026 | Sell | -642 | 364.00 USD | $233.7K | SEC |
| Jun 15, 2026 | Sell | -1,517 | 349.79 USD | $530.6K | SEC |
| Jun 15, 2026 | Sell | -1,331 | 355.50 USD | $473.2K | SEC |
| Jun 15, 2026 | Sell | -2,300 | 364.41 USD | $838.1K | SEC |
| Jun 15, 2026 | Sell | -2,708 | 362.40 USD | $981.4K | SEC |
| Jun 15, 2026 | Sell | -819 | 361.21 USD | $295.8K | SEC |
| Jun 15, 2026 | Sell | -2,832 | 345.84 USD | $979.4K | SEC |
| Jun 15, 2026 | Sell | -1,200 | 365.16 USD | $438.2K | SEC |
| Jun 15, 2026 | Sell | -300 | 355.71 USD | $106.7K | SEC |
| Jun 15, 2026 | Sell | -1,070 | 341.81 USD | $365.7K | SEC |